DK2744519T3 - Sammensætninger til foryngelse af hud - Google Patents
Sammensætninger til foryngelse af hud Download PDFInfo
- Publication number
- DK2744519T3 DK2744519T3 DK12823411.9T DK12823411T DK2744519T3 DK 2744519 T3 DK2744519 T3 DK 2744519T3 DK 12823411 T DK12823411 T DK 12823411T DK 2744519 T3 DK2744519 T3 DK 2744519T3
- Authority
- DK
- Denmark
- Prior art keywords
- formulation
- skin
- pfc
- approx
- mixture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
- A61K8/70—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine containing perfluoro groups, e.g. perfluoroethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
- A61K8/315—Halogenated hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D83/00—Containers or packages with special means for dispensing contents
- B65D83/14—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
- B65D83/16—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant characterised by the actuating means
- B65D83/20—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant characterised by the actuating means operated by manual action, e.g. button-type actuator or actuator caps
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D83/00—Containers or packages with special means for dispensing contents
- B65D83/14—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
- B65D83/75—Aerosol containers not provided for in groups B65D83/16 - B65D83/74
- B65D83/752—Aerosol containers not provided for in groups B65D83/16 - B65D83/74 characterised by the use of specific products or propellants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/22—Gas releasing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/591—Mixtures of compounds not provided for by any of the codes A61K2800/592 - A61K2800/596
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/87—Application Devices; Containers; Packaging
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Dispersion Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mechanical Engineering (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Claims (13)
1. Formulering der omfatter: ca. 1-10% af en blanding af perfluorcarbonatomer (PFC'er) med mindst tre forskellige molekylære vægte; og ca. 0,001-5% hyaluronsyre (HA) med molekylær vægt på ca. 100 kDa eller mindre, fyldt i en håndholdt aerosolspraybeholder.
2. Formulering ifølge krav 1, hvor formuleringen er vandholdig eller omfatter en olie- og vandemulsion.
3. Formulering ifølge et hvilket som helst af kravene 1-2, hvor blandingen af PFC'er omfatter perfluorpropan, perfluorbutan, perfluorpentan, perfluorhexan, perfluordecalin, perfluordimethyl-cyclohexan, perfluorperhydrophenanthren, pentafluorpropan, perfluortripropylamin, C6-C9-perfluoralkaner, perfluorperhydrofluoranthren, perfluordecalin, perfluorperhydro-phenanthren, bis(perfluor-hexyl)-l,2-ethen, perfluor-l,3-dimethylcyclohexan, perfluor-methyldecalin, perfluorisopropyldecalin, en blanding af perfluordixylylmethan og perfluordixylylethan, og/eller en blanding af perfluorperhydrophenanthren og perfluor-n-butyl-decalin.
4. Formulering ifølge et hvilket som helst af kravene 1-3, hvor formuleringen ikke omfatter mere end 5% af blandingen af PFC'er.
5. Formulering ifølge et hvilket som helst af kravene 1-3, hvor formuleringen omfatter ca. 10% af blandingen af PFC'er.
6. Formulering ifølge et hvilket som helst af kravene 1-5, hvor formuleringen endvidere omfatter en eller flere af niacin eller andre vitaminer, mineraler, enzymer, aminosyrer, antioxidanter, blodudvidende ingredienser eller naturlige behagelige dufte.
7. Formulering ifølge et hvilket som helst af kravene 1-6, endvidere omfattende en eller flere af: en intracellulær oxygenbooster (0,005-30%); emulgatorer (0,1- 20%); rheologimodifikatorer (0,05-5%); fugtighedsbevarende stoffer (0,5-8%); overfladeaktive midler (0,1-5%); blødgørende midler (0,1-20%); pH-modifikatorer (0,005-2%); antimikrobielle midler (0,001-3%); farvestoffer (0,001-30%); aromaer (0,005-5%); eller antioxidanter (0,005-5%).
8. Formulering ifølge krav 7, hvor den intracellulære oxygenbooster er et ekstrakt fra Tropaeolum Majus blomst/blad/stilk; emulgatoren er en ikke-ionisk, kationisk, anionisk eller polymerisk emulgator; rheologimodifikatoren er en polyacrylsyrepolymer, xanthangummi, cellulosegummi, silicat, alginat, eller hydrocolloid; det fugtighedsbevarende middel er propandiol, glycerin eller en anden glycol; det overfladeaktive middel er kationisk, anionisk, ethoxyleret eller ikke-ethoxyleret; det antimikrobielle middel er salicylsyre eller et konserveringsmiddel; farvestoffet er en FD&C-farve, jernoxid, eller titaniumdioxid; aromaen er i form af en duft eller æterisk olie; og antioxidanten er ascorbinsyre.
9. Formulering ifølge et hvilket som helst af kravene 1-8, hvor (a) den molekylære vægt af HA'en er mindre end eller ca. 50 kDa; (b) HA er i en mængde på ca. 0,1%; eller (c) den molekylære vægt af HA'en er mindre end eller ca. 50 kDa og HA er i en mængde på ca. 0,1%.
10. Formulering ifølge et hvilket som helst af kravene 1-9, hvor formuleringen er delvist mættet, mættet eller overmættet med oxygen.
11. Formulering ifølge krav 1, hvor formuleringen omfatter: vand/aqua/eau, perfluorhexan, perfluorperhydrophenanthren, dimethicon, propandiol, neopentylglycoldiheptanoat, perfluordecalin, ekstrakt fra Tropaeolum Majus blomst/blad/stilk, isododecan, cyclopentasiloxan, glycerylstearat, cetearylalkohol, stearinsyre, natriumlauroylglutamat, cyclohexasiloxan, acrylater/C10-30-alkylacrylat-krydspolymer, hydrolyseret hyaluronsyre, phospholipider, retinylpalmitat, tocopherylacetat, ascorbylpalmitat, natriumhydroxid, ehylhexylglycerin, kamilleolie og phenoxyethanol.
12. Anvendelse af formuleringen ifølge et hvilket som helst af kravene 1-11 i en kosmetikfremgangsmåde.
13. Anvendelse ifølge krav 12 hvor formuleringen anvendes: (a) som en foundation til make-up, hvor formuleringen endvidere omfatter et eller flere egnede farvestoffer; (b) til at øge hudfugtighed, og/eller reducere fine linjer og rynker; eller (c) til behandling af cellulit, hvor formuleringen endvidere omfatter adipogeneseinhibitorer, lipogeneseinhibitorer og/eller eller lipolytiske midler.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161524021P | 2011-08-16 | 2011-08-16 | |
PCT/US2012/051158 WO2013025916A2 (en) | 2011-08-16 | 2012-08-16 | Dermal rejuvenation compositions and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2744519T3 true DK2744519T3 (da) | 2019-01-21 |
Family
ID=47712828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK12823411.9T DK2744519T3 (da) | 2011-08-16 | 2012-08-16 | Sammensætninger til foryngelse af hud |
Country Status (14)
Country | Link |
---|---|
US (8) | US8980227B2 (da) |
EP (1) | EP2744519B1 (da) |
KR (1) | KR20140089340A (da) |
CN (2) | CN107412001B (da) |
AU (2) | AU2012296465B2 (da) |
CA (1) | CA2845570A1 (da) |
DK (1) | DK2744519T3 (da) |
ES (1) | ES2703516T3 (da) |
HK (3) | HK1199208A1 (da) |
HR (1) | HRP20182175T1 (da) |
PL (1) | PL2744519T3 (da) |
PT (1) | PT2744519T (da) |
TW (1) | TW201321022A (da) |
WO (1) | WO2013025916A2 (da) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012003457A1 (en) * | 2010-07-01 | 2012-01-05 | Mtm Research Llc | Anti-fibroblastic fluorochemical emulsion therapies |
US10610294B2 (en) | 2012-04-22 | 2020-04-07 | Newuro, B.V. | Devices and methods for transurethral bladder partitioning |
US9132295B2 (en) * | 2013-08-23 | 2015-09-15 | Indermica, Inc. | Composition having stabilized perfluorocarbons |
CN106232130A (zh) * | 2014-03-21 | 2016-12-14 | St&T国际股份有限公司 | 大麻提取方法和组合物 |
US20160303043A1 (en) * | 2015-04-16 | 2016-10-20 | Kate Somerville Skincare, LLC | Self-foaming compositions and methods |
WO2016185066A1 (es) * | 2015-05-15 | 2016-11-24 | Beautygun S.L. | Procedimiento cosmético para reducir las arrugas de la piel |
ITUB20152498A1 (it) * | 2015-07-24 | 2017-01-24 | Nati Srl | Composizione cosmetica anti-invecchiamento e metodo per la sua preparazione |
US9925137B2 (en) * | 2015-08-19 | 2018-03-27 | Maple Mountain Group, Inc. | Skin rejuvenation and defense system |
US10660419B2 (en) | 2016-12-15 | 2020-05-26 | Elc Management Llc | Packaged skin treatment composition and method |
US10076484B1 (en) | 2017-05-01 | 2018-09-18 | Robert Baron | Formulation and method of conditioning skin and preserving cosmetics applied thereto |
US20200038308A1 (en) * | 2018-08-06 | 2020-02-06 | Kate Somerville Skincare, LLC | Wrinkle reducing compositions and methods |
CN113164361B (zh) * | 2018-12-06 | 2024-04-02 | 高露洁-棕榄公司 | 个人护理组合物 |
CN112972757A (zh) * | 2021-03-05 | 2021-06-18 | 江苏菌均君隽生物科技有限公司 | 一种全氟萘烷水凝胶促愈合敷料及其制备方法和用途 |
CN112999410B (zh) * | 2021-03-05 | 2022-11-15 | 江苏君隽生物科技有限公司 | 含全氟萘烷的纳米氧合水凝胶促愈合敷料及其制法和用途 |
WO2023235544A1 (en) * | 2022-06-03 | 2023-12-07 | Colgate-Palmolive Company | Skin care compositions and methods of use |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2280360A1 (fr) | 1974-08-02 | 1976-02-27 | Sogeras | Composition cosmetologique oxygenante |
JPS6293211A (ja) | 1985-10-17 | 1987-04-28 | Shiseido Co Ltd | エアゾ−ル組成物 |
GB8821129D0 (en) | 1988-09-09 | 1988-10-12 | Unilever Plc | Cosmetic composition |
US5733572A (en) * | 1989-12-22 | 1998-03-31 | Imarx Pharmaceutical Corp. | Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles |
US5542935A (en) * | 1989-12-22 | 1996-08-06 | Imarx Pharmaceutical Corp. | Therapeutic delivery systems related applications |
DE4221268C2 (de) | 1992-06-26 | 1997-06-12 | Lancaster Group Ag | Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut |
US5840309A (en) | 1994-10-03 | 1998-11-24 | La Prairie Sa | Stimulating fibroblasts and/or keratinocytes |
TW504387B (en) | 1995-09-06 | 2002-10-01 | Kao Corp | Emulsified, water-in-oil type composition and skin cosmetic preparation |
US5738859A (en) | 1997-01-17 | 1998-04-14 | Abbe Cosmetic Group International, Inc. | Cosmetic composition |
US5972360A (en) | 1998-09-03 | 1999-10-26 | Braun; Darian | Self-tanning towelette |
GB9913408D0 (en) * | 1999-06-10 | 1999-08-11 | Albright & Wilson Uk Ltd | Personal care formulations |
US6762158B2 (en) * | 1999-07-01 | 2004-07-13 | Johnson & Johnson Consumer Companies, Inc. | Personal care compositions comprising liquid ester mixtures |
CA2436427A1 (en) * | 2001-02-01 | 2002-08-08 | Hydron Technologies, Inc. | Compositions and method of tissue superoxygenation |
US20030103922A1 (en) | 2001-11-20 | 2003-06-05 | Avon Products, Inc. | Renewable textured cosmetic compositions |
ITMI20020756A1 (it) * | 2002-04-09 | 2003-10-09 | Sinclair Pharma S R L | Composizioni farmaceutiche topiche per il trattamento delle dermatiti |
US7357937B2 (en) * | 2002-09-24 | 2008-04-15 | Therox, Inc. | Perfluorocarbon emulsions with non-fluorinated surfactants |
DE10245727A1 (de) | 2002-10-01 | 2004-04-15 | Beiersdorf Ag | Als Aerosol versprühbare W/O-Emulsionen |
WO2008000260A1 (en) * | 2006-06-28 | 2008-01-03 | Novozymes Biopolymer A/S | Compositions with several hyaluronic acid fractions for cosmetic and medical uses |
KR20080026924A (ko) * | 2006-09-22 | 2008-03-26 | 주식회사 바이오랜드 | 저분자량 히알루론산 또는 그 염을 함유하는 조성물 |
JP5532532B2 (ja) * | 2007-06-25 | 2014-06-25 | ダイキン工業株式会社 | 低分子量ポリテトラフルオロエチレン水性分散液及びその製造方法 |
WO2009102487A2 (en) * | 2008-02-13 | 2009-08-20 | Oxygen Biotherapeutics, Inc. | Gas based wound and tissue therapeutics |
US8343515B2 (en) * | 2008-11-25 | 2013-01-01 | Oxygen Biotherapeutics, Inc. | Perfluorocarbon gel formulations |
US20110044920A1 (en) | 2009-08-07 | 2011-02-24 | Mary Kay Inc. | Topical skin care formulations |
-
2012
- 2012-08-16 US US13/587,545 patent/US8980227B2/en active Active
- 2012-08-16 KR KR1020147006870A patent/KR20140089340A/ko not_active Application Discontinuation
- 2012-08-16 CN CN201611028183.3A patent/CN107412001B/zh active Active
- 2012-08-16 EP EP12823411.9A patent/EP2744519B1/en active Active
- 2012-08-16 TW TW101129715A patent/TW201321022A/zh unknown
- 2012-08-16 WO PCT/US2012/051158 patent/WO2013025916A2/en unknown
- 2012-08-16 CA CA2845570A patent/CA2845570A1/en not_active Abandoned
- 2012-08-16 DK DK12823411.9T patent/DK2744519T3/da active
- 2012-08-16 PL PL12823411T patent/PL2744519T3/pl unknown
- 2012-08-16 PT PT12823411T patent/PT2744519T/pt unknown
- 2012-08-16 CN CN201280050832.3A patent/CN104010662B/zh active Active
- 2012-08-16 ES ES12823411T patent/ES2703516T3/es active Active
- 2012-08-16 AU AU2012296465A patent/AU2012296465B2/en not_active Ceased
-
2013
- 2013-03-04 US US13/783,930 patent/US8980228B2/en active Active
-
2014
- 2014-12-22 HK HK14112762.5A patent/HK1199208A1/xx not_active IP Right Cessation
-
2015
- 2015-02-24 US US14/629,687 patent/US20150164770A1/en not_active Abandoned
- 2015-02-26 HK HK15101912.6A patent/HK1201442A1/xx not_active IP Right Cessation
-
2016
- 2016-04-25 US US15/137,259 patent/US20160235647A1/en not_active Abandoned
- 2016-10-12 US US15/291,648 patent/US20170027841A1/en not_active Abandoned
-
2017
- 2017-05-18 US US15/598,937 patent/US20170367959A1/en not_active Abandoned
- 2017-05-29 AU AU2017203594A patent/AU2017203594B2/en not_active Ceased
-
2018
- 2018-04-11 US US15/950,742 patent/US20180228715A1/en not_active Abandoned
- 2018-05-31 HK HK18107118.2A patent/HK1247566A1/zh unknown
- 2018-11-21 US US16/198,103 patent/US20190151220A1/en not_active Abandoned
- 2018-12-21 HR HRP20182175TT patent/HRP20182175T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2017203594B2 (en) | Dermal rejuvenation compositions and methods | |
US4983382A (en) | Cosmetic preparation incorporating stabilized ascorbic acid | |
KR100837558B1 (ko) | 이중으로 안정된 세라마이드 나노 캡슐 포함 에멀젼조성물, 그의 제조방법 및 이를 이용한 피부 화장료 조성물 | |
US20210393507A1 (en) | Extemporaneous cosmetic and/or dermatological preparations | |
CN105687059A (zh) | 一种用于抗衰老的化妆品组合物及其配制方法、应用 | |
US9452113B2 (en) | Method for treating oily skin | |
WO2020033450A1 (en) | Wrinkle reducing compositions and methods | |
KR20160141297A (ko) | 피부 탄력에 효과를 갖는 마유를 함유하는 피부 재생용 화장료 조성물 및 이의 제조방법 | |
KR20090054777A (ko) | 피부의 pΗ 조절용 조성물 및 이를 포함하는 화장품 | |
CN106389234B (zh) | 抗衰组合物和化妆品 | |
KR101502027B1 (ko) | 바오밥 나무 열매 추출물과 콜라겐 펩타이드를 함유하는 피부 보습 및 탄력 개선 화장료 조성물 | |
JP6957228B2 (ja) | 美容方法 | |
US20210022966A1 (en) | Use of a dry film for cosmetic topical applications | |
Somwanshi et al. | Cosmetic Science | |
KR20100033729A (ko) | N-아세틸글루코사민과 비타민 c를 함유하는 화장료 조성물 | |
JP2021098669A (ja) | 皮膚化粧料 | |
Mayangsari et al. | The Effect of Essential Oil Types on The Physical Characteristics and Consumer Preference Level of Antiaging Body Lotion that Contain NLC-Coenzyme Q10 | |
CN117999062A (zh) | 松弛毛孔改善剂 | |
JPH1192327A (ja) | 清涼感組成物 | |
HU221141B1 (en) | Composition for cellulite treatments and process for its preparation |